Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes

Herein, we describe recruitment efforts for a trial of lipid-lowering medications in adolescents with type 1 diabetes, age 12–21 years. Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishop, Franziska K, Wadwa, R Paul, Ellis, Sam, Rewers, Marian, Maahs, David M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476991/
https://www.ncbi.nlm.nih.gov/pubmed/22846167
http://dx.doi.org/10.1186/1687-9856-2012-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476991/
https://www.ncbi.nlm.nih.gov/pubmed/22846167
http://dx.doi.org/10.1186/1687-9856-2012-24

Ejemplares similares